High dose chemotherapy helps combat neuroblastoma

Ipilimumab improves survival in metastatic melanoma

Exemestane significantly reduces risk of invasive breast cancer in high-risk, postmenopausal women

New melanoma drug gives 63 percent reduction in risk of death compared to dacarbazine

Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence

Ethics of early-phase clinical trials

Susan G. Komen for the Cure; worldwide breast cancer advocacy

ASCO 2011 highlights

Autologous stem cell transplantation

Advanced biological imaging technology

Heterogeneity of tumours influences treatment

Second generation TKIs in chronic myeloid leukaemia